Clinical Trial Update: Study of Everolimus as Maintenance Therapy for Metastatic NEC With Pulmonary or Gastroenteropancreatic Origin [Phase 2]

View source ↗

Summary

Phase 2 trial investigating everolimus as maintenance therapy for metastatic neuroendocrine carcinoma of pulmonary or gastroenteropancreatic origin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroendocrine Carcinoma

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Gruppo Oncologico Italiano di Ricerca Clinica | Conditions: Neuroendocrine Carcinoma | Phase 2 | Status: UNKNOWN